Physiotherapy for Urinary Incontinence in Gynecologic Cancer Survivors
Trial Summary
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the idea that Physiotherapy for Urinary Incontinence in Gynecologic Cancer Survivors is an effective treatment?
The available research shows that pelvic floor muscle training (PFMT), a type of physiotherapy, is effective for women with urinary incontinence. It is the most commonly used physical therapy for stress urinary incontinence and is also recommended for mixed and urgency urinary incontinence. Studies indicate that PFMT can improve symptoms and is often used alongside other methods like feedback to enhance its effectiveness. This suggests that physiotherapy is a beneficial treatment for urinary incontinence in women, including those who are gynecologic cancer survivors.12345
What data supports the effectiveness of the treatment Physiotherapy, Pelvic Floor Physical Therapy, Pelvic Health Physiotherapy, PFMT (Pelvic Floor Muscle Training) for urinary incontinence?
Research shows that pelvic floor muscle training (PFMT) is an effective treatment for stress urinary incontinence in women and is sometimes recommended for mixed and urgency urinary incontinence. It is a commonly used therapy that helps improve bladder control by strengthening the pelvic floor muscles.12345
What safety data exists for physiotherapy for urinary incontinence in gynecologic cancer survivors?
The research indicates that pelvic floor muscle training (PFMT), a form of physiotherapy, is commonly used and recommended for urinary incontinence in women. It is considered safe and is often compared to no treatment or inactive control treatments in systematic reviews and meta-analyses. However, specific safety data for gynecologic cancer survivors is not directly addressed in the provided studies, though PFMT is generally accepted as a safe intervention for urinary incontinence.14678
Is physiotherapy for urinary incontinence safe for gynecologic cancer survivors?
Is physiotherapy a promising treatment for urinary incontinence in gynecologic cancer survivors?
Yes, physiotherapy, specifically pelvic floor muscle training, is a promising treatment for urinary incontinence. It is commonly used to help women with stress urinary incontinence and can also be beneficial for other types of urinary issues. This treatment is non-invasive, can be combined with other therapies, and has shown good results in improving symptoms.158910
How is physiotherapy different from other treatments for urinary incontinence in gynecologic cancer survivors?
Physiotherapy for urinary incontinence, specifically pelvic floor muscle training, is unique because it is a non-invasive treatment that focuses on strengthening and coordinating the pelvic floor muscles to improve bladder control. Unlike medications or surgical options, it involves exercises, manual therapy, and sometimes biofeedback or electrical stimulation, making it a first-choice treatment due to its low risk of side effects and ability to be combined with other therapies.158910
What is the purpose of this trial?
The aims of this pilot study are to examine the feasibility and to explore the effects of a physiotherapy treatment compared to standard usual care in gynecological cancer survivors with urinary incontinence in preparation of a large randomized controlled study.
Eligibility Criteria
This trial is for women who have survived gynecological cancers like endometrial or cervical cancer and are now experiencing urinary incontinence at least three times a week. They should be done with their scheduled cancer treatments but haven't had pelvic floor rehab in the past year, and don't have other conditions that could affect the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either 12-weekly physiotherapy treatment sessions or continue standard usual care for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Physiotherapy
Physiotherapy is already approved in European Union, United States, Canada for the following indications:
- Urinary incontinence in gynecological cancer survivors
- Pelvic pain
- Sexual dysfunction
- Urinary incontinence in gynecological cancer survivors
- Pelvic pain
- Sexual dysfunction
- Urinary incontinence in gynecological cancer survivors
- Pelvic pain
- Sexual dysfunction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université de Sherbrooke
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborator
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Collaborator
Institut Universitaire de Gériatrie de Montréal
Collaborator
Jewish General Hospital
Collaborator